Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Biotheus
company
About
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Biotheus is an up-and-coming biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus is committed to research and development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$100M ¥100M
Biotheus has raised a total of
$100M ¥100M
in funding over 2 rounds. Their latest funding was raised on
Mar 2, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 2, 2021 | Series D | $100M | 1 | — | — | Detail |
| Jun 26, 2019 | Seed | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Biotheus is funded by 2 investors.
Huajin Fund
and Zhuhai Huajin Asset
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
